Copyright
©The Author(s) 2016.
World J Hepatol. Dec 18, 2016; 8(35): 1569-1575
Published online Dec 18, 2016. doi: 10.4254/wjh.v8.i35.1569
Published online Dec 18, 2016. doi: 10.4254/wjh.v8.i35.1569
Demographics | Median QFM (95%CI) IU/mL | |
Age (median, yr) | 54 (20-72) | 94.5 (37.3-158) |
Male | 62 (68.1%) | 124.5 (37.3-223) |
Female | 29 (31.9%) | 73.9 (7.50-158) |
Child-Pugh score | ||
A | 7 | 381 (12.9-1234) |
B | 29 | 224 (94.4-506) |
C | 55 | 37.3 (19.5-128) |
MELD score | ||
0-10 | 10 | 319 (12.9-904) |
11-20 | 42 | 155.5 (94.5-240) |
21-30 | 34 | 30.0 (9.16-157) |
≥ 30 | 5 | 8.81 (0.63-47.6) |
Primary aetiology of cirrhosis, n (%) | ||
HCV | 39 (42.9) | 130 (47.6-223) |
PSC | 10 (11.0) | 61.6 (1.19-279) |
ETOH | 10 (11.0) | 113.3 (8.81-385) |
NASH | 9 (9.89) | 20.3 (6.20-375) |
AIH | 5 (5.49) | 37.3 (0.04-137) |
PBC | 4 (4.40) | 93.0 (24.1-168) |
HBV | 3 (3.30) | 904 (799-1132) |
Retransplant | 3 (3.30) | 163 (2.06-318) |
Other | 8 (8.79) | 6.59 (0.07-774) |
HCC | 31 (34.1) | 194 (87.9-425) |
No HCC | 61 (65.9) | 73.9 (28.0-154) |
Coefficient | P vaule | 95%CI | |
MELD score | -17.3 | < 0.001 | -25.3:-9.29 |
Child-Pugh score | -65.6 | < 0.001 | -91.1:-40.2 |
Alcohol | -69.3 | 0.285 | -197.4:58.7 |
HCC | 193.9 | 0.002 | 71.6:316.1 |
Age | 3.18 | 0.252 | -2.30:8.66 |
WCC | -9.4 | 0.351 | -29.2:10.5 |
Neutrophils | -19.0 | 0.137 | -44.1:6.17 |
HCV | -44.4 | 0.476 | -168.0:79.1 |
Male | 70.1 | 0.288 | -60.1:200.4 |
Bilirubin | -0.59 | 0.001 | -0.95:-0.24 |
Urea | -14.5 | 0.023 | -26.9:-2.00 |
Creatinine | 0.17 | 0.702 | -0.71:1.06 |
Haemoglobin | 5.04 | < 0.001 | 2.48:7.59 |
Platelets | 0.59 | 0.164 | -0.24:1.42 |
Albumin | 9.50 | 0.055 | -0.21:19.2 |
INR | -230.6 | < 0.001 | -342:-119 |
Coefficent | P vaule | 95%CI | |
Child-Pugh score | -51.9 | 0.013 | -92.6:-11.3 |
MELD score | 16.0 | 0.131 | -4.88:36.9 |
HCC | 62.9 | 0.366 | -74.8:201 |
Bilirubin | -0.39 | 0.131 | -0.91:0.120 |
Urea | -14.3 | 0.046 | -28.3:-0.261 |
Haemoglobin | 1.77 | 0.250 | -1.27:4.82 |
Albumin | 7.15 | 0.141 | -2.43:16.7 |
INR | -114 | 0.168 | -278:49.3 |
- Citation: Sood S, Yu L, Visvanathan K, Angus PW, Gow PJ, Testro AG. Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients. World J Hepatol 2016; 8(35): 1569-1575
- URL: https://www.wjgnet.com/1948-5182/full/v8/i35/1569.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i35.1569